PLA2G2A Human (+)-catechin multiple interactions EXP 6480464 [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of PLA2G2A mRNA CTD PMID:24763279 PLA2G2A Human 1,2-dimethylhydrazine increases expression ISO Pla2g2a (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in increased expression of PLA2G2A mRNA CTD PMID:22206623 PLA2G2A Human 17alpha-ethynylestradiol affects expression ISO Pla2g2a (Mus musculus) 6480464 Ethinyl Estradiol affects the expression of PLA2G2A mRNA CTD PMID:17555576 PLA2G2A Human 17alpha-ethynylestradiol multiple interactions ISO Pla2g2a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLA2G2A mRNA CTD PMID:17942748 PLA2G2A Human 17alpha-ethynylestradiol increases expression ISO Pla2g2a (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of PLA2G2A mRNA CTD PMID:17942748 PLA2G2A Human 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of PLA2G2A protein CTD PMID:18191855 PLA2G2A Human 17beta-estradiol multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2A mRNA CTD PMID:32741896 PLA2G2A Human 17beta-estradiol 3-benzoate multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2A mRNA CTD PMID:32741896 PLA2G2A Human 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Pla2g2a (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of PLA2G2A mRNA CTD PMID:17942748 PLA2G2A Human 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of PLA2G2A mRNA CTD PMID:33387578 PLA2G2A Human 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Pla2g2a (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin affects the expression of PLA2G2A mRNA CTD PMID:34747641 PLA2G2A Human 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G2A mRNA CTD PMID:20106945 more ... PLA2G2A Human 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Tetrachlorodibenzodioxin results in increased expression of PLA2G2A mRNA CTD PMID:20566336 PLA2G2A Human 2,3,7,8-Tetrachlorodibenzofuran increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 2 more ... CTD PMID:32109520 PLA2G2A Human 2,4,6-trinitrobenzenesulfonic acid multiple interactions ISO Pla2g2a (Mus musculus) 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PLA2G2A mRNA] CTD PMID:18200517 PLA2G2A Human 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Pla2g2a (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of PLA2G2A mRNA CTD PMID:17982090 and PMID:18200517 PLA2G2A Human 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G2A mRNA] and IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G2A mRNA] CTD PMID:17109745 PLA2G2A Human 2-amino-2-deoxy-D-glucopyranose decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of PLA2G2A mRNA CTD PMID:17109745 PLA2G2A Human 3-isobutyl-1-methyl-7H-xanthine multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PLA2G2A mRNA CTD PMID:28628672 PLA2G2A Human 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of PLA2G2A mRNA CTD PMID:24835565 PLA2G2A Human 5-aza-2'-deoxycytidine decreases methylation EXP 6480464 Decitabine results in decreased methylation of PLA2G2A promoter CTD PMID:18953428 PLA2G2A Human 5-aza-2'-deoxycytidine multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [IFNG protein promotes the reaction [Decitabine results in increased expression of PLA2G2A protein]] more ... CTD PMID:18953428 PLA2G2A Human 5-aza-2'-deoxycytidine affects expression EXP 6480464 Decitabine affects the expression of PLA2G2A mRNA CTD PMID:23300844 PLA2G2A Human 5-aza-2'-deoxycytidine increases expression EXP 6480464 Decitabine results in increased expression of PLA2G2A mRNA and Decitabine results in increased expression of PLA2G2A protein CTD PMID:18320072 and PMID:18953428 PLA2G2A Human acetic acid increases expression ISO Pla2g2a (Mus musculus) 6480464 Acetic Acid results in increased expression of PLA2G2A protein CTD PMID:33002459 PLA2G2A Human acetic acid multiple interactions ISO Pla2g2a (Mus musculus) 6480464 Melitten inhibits the reaction [Acetic Acid results in increased expression of PLA2G2A protein] CTD PMID:33002459 PLA2G2A Human aflatoxin B1 increases methylation EXP 6480464 Aflatoxin B1 results in increased methylation of PLA2G2A gene CTD PMID:27153756 PLA2G2A Human aflatoxin M1 decreases expression EXP 6480464 Aflatoxin M1 results in decreased expression of PLA2G2A mRNA CTD PMID:30928695 PLA2G2A Human aldehydo-D-glucosamine multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G2A mRNA] and IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G2A mRNA] CTD PMID:17109745 PLA2G2A Human aldehydo-D-glucosamine decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of PLA2G2A mRNA CTD PMID:17109745 PLA2G2A Human all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of PLA2G2A mRNA CTD PMID:16249480 and PMID:23830798 PLA2G2A Human alpha-Zearalanol increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Zeranol results in increased expression of PLA2G2A mRNA CTD PMID:35163327 PLA2G2A Human alpha-Zearalanol multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PLA2G2A mRNA CTD PMID:35163327 PLA2G2A Human amiodarone increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Amiodarone results in increased expression of PLA2G2A mRNA CTD PMID:25580480 PLA2G2A Human ammonium chloride affects expression ISO Pla2g2a (Rattus norvegicus) 6480464 Ammonium Chloride affects the expression of PLA2G2A mRNA CTD PMID:16483693 PLA2G2A Human amphetamine increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Amphetamine results in increased expression of PLA2G2A mRNA CTD PMID:30779732 PLA2G2A Human amphotericin B increases expression EXP 6480464 Amphotericin B analog results in increased expression of PLA2G2A mRNA CTD PMID:28534445 PLA2G2A Human anthocyanin increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Anthocyanins results in increased expression of PLA2G2A mRNA CTD PMID:18803703 PLA2G2A Human antirheumatic drug decreases expression EXP 6480464 Antirheumatic Agents results in decreased expression of PLA2G2A mRNA CTD PMID:24449571 PLA2G2A Human baicalein multiple interactions ISO Pla2g2a (Mus musculus) 6480464 baicalein inhibits the reaction [PLA2G2A protein results in increased expression of PTGS2 protein] more ... CTD PMID:31811862 PLA2G2A Human belinostat increases expression EXP 6480464 belinostat results in increased expression of PLA2G2A mRNA CTD PMID:26272509 PLA2G2A Human belinostat multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 PLA2G2A Human benzo[a]pyrene affects methylation EXP 6480464 Benzo(a)pyrene affects the methylation of PLA2G2A promoter CTD PMID:27901495 PLA2G2A Human benzo[a]pyrene increases methylation EXP 6480464 Benzo(a)pyrene results in increased methylation of PLA2G2A 5' UTR CTD PMID:27901495 PLA2G2A Human beta-D-glucosamine multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of PLA2G2A mRNA] and IL1B inhibits the reaction [Glucosamine results in decreased expression of PLA2G2A mRNA] CTD PMID:17109745 PLA2G2A Human beta-D-glucosamine decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Glucosamine results in decreased expression of PLA2G2A mRNA CTD PMID:17109745 PLA2G2A Human betulinic acid affects binding EXP 6480464 Betulinic Acid binds to PLA2G2A protein CTD PMID:29391000 PLA2G2A Human bis(2-ethylhexyl) phthalate decreases expression EXP 6480464 Diethylhexyl Phthalate results in decreased expression of PLA2G2A mRNA CTD PMID:28412506 and PMID:31163220 PLA2G2A Human bisphenol A affects expression ISO Pla2g2a (Rattus norvegicus) 6480464 bisphenol A affects the expression of PLA2G2A mRNA CTD PMID:25181051 PLA2G2A Human bisphenol A decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 bisphenol A results in decreased expression of PLA2G2A mRNA CTD PMID:32145629 PLA2G2A Human bisphenol A decreases methylation ISO Pla2g2a (Mus musculus) 6480464 bisphenol A results in decreased methylation of PLA2G2A promoter CTD PMID:27312807 PLA2G2A Human C60 fullerene increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 fullerene C60 results in increased expression of PLA2G2A mRNA CTD PMID:19167457 PLA2G2A Human cadmium atom decreases expression EXP 6480464 Cadmium results in decreased expression of PLA2G2A mRNA CTD PMID:24376830 PLA2G2A Human cadmium atom increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Cadmium results in increased expression of PLA2G2A mRNA CTD PMID:25808797 PLA2G2A Human calcium atom increases uptake ISO Pla2g2a (Rattus norvegicus) 6480464 PLA2G2A protein results in increased uptake of Calcium CTD PMID:15695168 PLA2G2A Human calcium atom multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 BQ 788 inhibits the reaction [EDN3 protein inhibits the reaction [PLA2G2A protein affects the uptake of Calcium]] and EDN3 protein inhibits the reaction [PLA2G2A protein affects the uptake of Calcium] CTD PMID:15695168 PLA2G2A Human calcium(0) increases uptake ISO Pla2g2a (Rattus norvegicus) 6480464 PLA2G2A protein results in increased uptake of Calcium CTD PMID:15695168 PLA2G2A Human calcium(0) multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 BQ 788 inhibits the reaction [EDN3 protein inhibits the reaction [PLA2G2A protein affects the uptake of Calcium]] and EDN3 protein inhibits the reaction [PLA2G2A protein affects the uptake of Calcium] CTD PMID:15695168 PLA2G2A Human CGP 52608 multiple interactions EXP 6480464 CGP 52608 promotes the reaction [RORA protein binds to PLA2G2A gene] CTD PMID:28238834 PLA2G2A Human chromium(6+) affects expression ISO Pla2g2a (Mus musculus) 6480464 chromium hexavalent ion affects the expression of PLA2G2A mRNA CTD PMID:28472532 PLA2G2A Human ciglitazone multiple interactions EXP 6480464 [ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLA2G2A mRNA CTD PMID:16197558 PLA2G2A Human cisplatin affects expression EXP 6480464 Cisplatin affects the expression of PLA2G2A mRNA CTD PMID:23300844 PLA2G2A Human clothianidin increases expression EXP 6480464 clothianidin results in increased expression of PLA2G2A mRNA CTD PMID:31626844 PLA2G2A Human colforsin daropate hydrochloride multiple interactions EXP 6480464 Colforsin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] CTD PMID:18953428 PLA2G2A Human curcumin multiple interactions ISO Pla2g2a (Mus musculus) 6480464 Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in increased expression of PLA2G2A mRNA] CTD PMID:18200517 PLA2G2A Human cyclosporin A decreases expression EXP 6480464 Cyclosporine results in decreased expression of PLA2G2A mRNA CTD PMID:20106945 and PMID:21632981 PLA2G2A Human cyclosporin A decreases methylation EXP 6480464 Cyclosporine results in decreased methylation of PLA2G2A promoter CTD PMID:27989131 PLA2G2A Human dexamethasone increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Dexamethasone results in increased expression of PLA2G2A mRNA CTD PMID:14618091 PLA2G2A Human dexamethasone multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PLA2G2A mRNA CTD PMID:28628672 PLA2G2A Human dexamethasone increases expression EXP 6480464 Dexamethasone results in increased expression of PLA2G2A mRNA CTD PMID:25047013 PLA2G2A Human dextran sulfate increases expression ISO Pla2g2a (Mus musculus) 6480464 Dextran Sulfate results in increased expression of PLA2G2A mRNA CTD PMID:23894361 PLA2G2A Human dibenzofuran multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 AHR protein promotes the reaction [dibenzofuran analog results in increased expression of PLA2G2A mRNA] CTD PMID:20566336 PLA2G2A Human dibenzofuran increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 dibenzofuran analog results in increased expression of PLA2G2A mRNA CTD PMID:20566336 PLA2G2A Human diethylstilbestrol increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Diethylstilbestrol results in increased expression of PLA2G2A mRNA CTD PMID:36653537 PLA2G2A Human dimethyl sulfoxide decreases expression EXP 6480464 Dimethyl Sulfoxide results in decreased expression of PLA2G2A mRNA CTD PMID:21878375 PLA2G2A Human dimethylarsinic acid multiple interactions ISO Pla2g2a (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA CTD PMID:34876320 PLA2G2A Human dimethylarsinic acid decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Cacodylic Acid results in decreased expression of PLA2G2A mRNA CTD PMID:37567419 PLA2G2A Human diuron decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Diuron results in decreased expression of PLA2G2A mRNA CTD PMID:21551480 PLA2G2A Human dorsomorphin multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 PLA2G2A Human EC 3.1.1.4 (phospholipase A2) inhibitor decreases expression EXP 6480464 Phospholipase A2 Inhibitors results in decreased expression of PLA2G2A mRNA CTD PMID:19765281 PLA2G2A Human EC 3.1.1.4 (phospholipase A2) inhibitor multiple interactions EXP 6480464 Phospholipase A2 Inhibitors inhibits the reaction [IL1B protein results in increased expression of PLA2G2A mRNA] and Phospholipase A2 Inhibitors inhibits the reaction [IL1B protein results in increased secretion of PLA2G2A protein] CTD PMID:19765281 PLA2G2A Human ellagic acid decreases expression EXP 6480464 Ellagic Acid results in decreased expression of PLA2G2A mRNA CTD PMID:20816778 PLA2G2A Human entinostat multiple interactions EXP 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 PLA2G2A Human entinostat increases expression EXP 6480464 entinostat results in increased expression of PLA2G2A mRNA CTD PMID:26272509 PLA2G2A Human erythromycin A decreases expression ISO Pla2g2a (Mus musculus) 6480464 Erythromycin results in decreased expression of PLA2G2A mRNA CTD PMID:27503388 PLA2G2A Human ethanol increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Ethanol results in increased expression of PLA2G2A protein CTD PMID:25029343 and PMID:29339456 PLA2G2A Human ethanol multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 Docosahexaenoic Acids inhibits the reaction [Ethanol results in increased expression of PLA2G2A protein] more ... CTD PMID:25029343 and PMID:29339456 PLA2G2A Human fenvalerate decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 fenvalerate results in decreased expression of PLA2G2A mRNA CTD PMID:30307764 PLA2G2A Human furan increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 furan results in increased expression of PLA2G2A mRNA CTD PMID:27387713 PLA2G2A Human genistein decreases expression EXP 6480464 Genistein results in decreased expression of PLA2G2A mRNA CTD PMID:20816778 PLA2G2A Human gentamycin decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Gentamicins results in decreased expression of PLA2G2A mRNA CTD PMID:33387578 PLA2G2A Human ibuprofen affects expression EXP 6480464 Ibuprofen affects the expression of PLA2G2A mRNA CTD PMID:17070997 PLA2G2A Human indometacin multiple interactions EXP 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PLA2G2A mRNA CTD PMID:28628672 PLA2G2A Human kaempferol 3-O-beta-D-galactoside affects activity EXP 6480464 kaempferol-3-O-galactoside affects the activity of PLA2G2A protein CTD PMID:8190018 PLA2G2A Human lead diacetate increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 lead acetate results in increased expression of PLA2G2A mRNA CTD PMID:11578147 PLA2G2A Human lidocaine decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Lidocaine results in decreased expression of PLA2G2A mRNA CTD PMID:35283115 PLA2G2A Human lipopolysaccharide increases expression ISO Pla2g2a (Mus musculus) 6480464 Lipopolysaccharides results in increased expression of PLA2G2A mRNA CTD PMID:29248447 PLA2G2A Human lipopolysaccharide increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Lipopolysaccharides results in increased expression of PLA2G2A mRNA and Lipopolysaccharides results in increased expression of PLA2G2A protein CTD PMID:21943492 PLA2G2A Human lipopolysaccharide multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 [Lipopolysaccharides co-treated with IFNG protein] results in increased expression of PLA2G2A mRNA more ... CTD PMID:21943492 PLA2G2A Human lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of PLA2G2A protein CTD PMID:15964894 PLA2G2A Human lipopolysaccharide multiple interactions EXP 6480464 [Lipopolysaccharides co-treated with IL1B protein co-treated with TNF protein co-treated with IFNG protein] results in increased expression of PLA2G2A mRNA CTD PMID:21878375 PLA2G2A Human lycopene multiple interactions EXP 6480464 lycopene inhibits the reaction [HMGB1 protein results in increased expression of and results in increased secretion of PLA2G2A protein] CTD PMID:22429818 PLA2G2A Human manganese(II) chloride increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 manganese chloride results in increased expression of PLA2G2A mRNA CTD PMID:28801915 PLA2G2A Human mangiferin decreases activity EXP 6480464 mangiferin results in decreased activity of PLA2G2A protein CTD PMID:15177302 PLA2G2A Human melittin multiple interactions ISO Pla2g2a (Mus musculus) 6480464 Melitten inhibits the reaction [Acetic Acid results in increased expression of PLA2G2A protein] CTD PMID:33002459 PLA2G2A Human methotrexate increases expression EXP 6480464 Methotrexate results in increased expression of PLA2G2A mRNA CTD PMID:17400583 PLA2G2A Human methylarsonic acid multiple interactions ISO Pla2g2a (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA CTD PMID:34876320 PLA2G2A Human mithramycin multiple interactions EXP 6480464 Plicamycin inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] CTD PMID:18953428 PLA2G2A Human N'-Nitrosonornicotine increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 N'-nitrosonornicotine results in increased expression of PLA2G2A mRNA CTD PMID:24835565 PLA2G2A Human N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of PLA2G2A mRNA CTD PMID:21527772 PLA2G2A Human nickel atom increases expression EXP 6480464 Nickel results in increased expression of PLA2G2A mRNA CTD PMID:25583101 PLA2G2A Human nitrofen increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 nitrofen results in increased expression of PLA2G2A mRNA CTD PMID:33484710 PLA2G2A Human olaparib multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 olaparib inhibits the reaction [Ethanol results in increased expression of PLA2G2A protein] CTD PMID:29339456 PLA2G2A Human paclitaxel increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Paclitaxel results in increased expression of PLA2G2A mRNA CTD PMID:18754875 PLA2G2A Human panobinostat multiple interactions EXP 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 PLA2G2A Human panobinostat increases expression EXP 6480464 panobinostat results in increased expression of PLA2G2A mRNA CTD PMID:26272509 PLA2G2A Human paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of PLA2G2A mRNA CTD PMID:29067470 PLA2G2A Human paracetamol decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Acetaminophen results in decreased expression of PLA2G2A mRNA CTD PMID:33387578 PLA2G2A Human paraquat increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Paraquat results in increased expression of PLA2G2A mRNA CTD PMID:32680482 PLA2G2A Human perfluorooctanoic acid increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 perfluorooctanoic acid results in increased expression of PLA2G2A mRNA CTD PMID:35163327 PLA2G2A Human perfluorooctanoic acid multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of PLA2G2A mRNA CTD PMID:35163327 PLA2G2A Human phenethyl caffeate multiple interactions EXP 6480464 caffeic acid phenethyl ester inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] CTD PMID:18953428 PLA2G2A Human phenobarbital increases expression ISO Pla2g2a (Mus musculus) 6480464 Phenobarbital results in increased expression of PLA2G2A mRNA CTD PMID:19482888 PLA2G2A Human phenobarbital increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Phenobarbital results in increased expression of PLA2G2A mRNA CTD PMID:19162173 PLA2G2A Human phenobarbital multiple interactions ISO Pla2g2a (Mus musculus) 6480464 NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PLA2G2A mRNA] CTD PMID:19482888 PLA2G2A Human phenylephrine decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Phenylephrine results in decreased expression of PLA2G2A mRNA CTD PMID:18158353 PLA2G2A Human phorbol 13-acetate 12-myristate multiple interactions EXP 6480464 Tetradecanoylphorbol Acetate inhibits the reaction [IFNG protein promotes the reaction [decitabine results in increased expression of PLA2G2A protein]] CTD PMID:18953428 PLA2G2A Human phosgene increases activity ISO Pla2g2a (Rattus norvegicus) 6480464 Phosgene results in increased activity of PLA2G2A protein CTD PMID:19235614 PLA2G2A Human pirinixic acid decreases expression ISO Pla2g2a (Mus musculus) 6480464 pirinixic acid results in decreased expression of PLA2G2A mRNA CTD PMID:17426115 PLA2G2A Human prostaglandin E2 increases expression EXP 6480464 Dinoprostone results in increased expression of PLA2G2A protein CTD PMID:15964894 PLA2G2A Human prothioconazole increases expression ISO Pla2g2a (Mus musculus) 6480464 prothioconazole results in increased expression of PLA2G2A mRNA CTD PMID:36007749 PLA2G2A Human quercetagetin affects activity EXP 6480464 quercetagetin affects the activity of PLA2G2A protein CTD PMID:8190018 PLA2G2A Human quercetin decreases expression EXP 6480464 Quercetin results in decreased expression of PLA2G2A mRNA CTD PMID:20816778 PLA2G2A Human quercetin increases expression EXP 6480464 Quercetin results in increased expression of PLA2G2A mRNA CTD PMID:21632981 PLA2G2A Human resveratrol multiple interactions EXP 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of PLA2G2A mRNA CTD PMID:23557933 PLA2G2A Human rofecoxib affects expression EXP 6480464 rofecoxib affects the expression of PLA2G2A mRNA CTD PMID:17070997 PLA2G2A Human rotenone decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Rotenone results in decreased expression of PLA2G2A mRNA CTD PMID:28374803 PLA2G2A Human SB 431542 multiple interactions EXP 6480464 [NOG protein co-treated with belinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 PLA2G2A Human scutellarin affects activity EXP 6480464 scutellarin affects the activity of PLA2G2A protein CTD PMID:8190018 PLA2G2A Human simvastatin multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 Simvastatin inhibits the reaction [Cholesterol and Dietary results in increased expression of PLA2G2A protein] CTD PMID:19237014 PLA2G2A Human sodium arsenate multiple interactions ISO Pla2g2a (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA CTD PMID:34876320 PLA2G2A Human sodium arsenite decreases expression ISO Pla2g2a (Mus musculus) 6480464 sodium arsenite results in decreased expression of PLA2G2A mRNA CTD PMID:22700541 PLA2G2A Human sodium arsenite multiple interactions ISO Pla2g2a (Mus musculus) 6480464 [sodium arsenate co-treated with sodium arsenite co-treated with monomethylarsonic acid co-treated with Cacodylic Acid] results in decreased expression of PLA2G2A mRNA CTD PMID:34876320 PLA2G2A Human sodium arsenite increases expression EXP 6480464 sodium arsenite results in increased expression of PLA2G2A mRNA CTD PMID:34032870 PLA2G2A Human sodium arsenite affects methylation EXP 6480464 sodium arsenite affects the methylation of PLA2G2A gene CTD PMID:28589171 PLA2G2A Human sodium dichromate increases expression ISO Pla2g2a (Rattus norvegicus) 6480464 sodium bichromate results in increased expression of PLA2G2A mRNA CTD PMID:22561333 PLA2G2A Human tamoxifen affects expression ISO Pla2g2a (Mus musculus) 6480464 Tamoxifen affects the expression of PLA2G2A mRNA CTD PMID:17555576 PLA2G2A Human testosterone multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of PLA2G2A mRNA CTD PMID:32741896 PLA2G2A Human tetracycline decreases expression ISO Pla2g2a (Mus musculus) 6480464 Tetracycline results in decreased expression of PLA2G2A mRNA CTD PMID:16917069 PLA2G2A Human thiram increases expression EXP 6480464 Thiram results in increased expression of PLA2G2A mRNA CTD PMID:38568856 PLA2G2A Human thromboxane A2 multiple interactions EXP 6480464 varespladib inhibits the reaction [PLA2G2A protein results in increased abundance of Thromboxane A2 metabolite] CTD PMID:10027849 PLA2G2A Human thromboxane A2 increases abundance EXP 6480464 PLA2G2A protein results in increased abundance of Thromboxane A2 metabolite CTD PMID:10027849 PLA2G2A Human thromboxane B2 multiple interactions EXP 6480464 varespladib inhibits the reaction [PLA2G2A protein results in increased abundance of Thromboxane B2] CTD PMID:10027849 PLA2G2A Human thromboxane B2 increases abundance EXP 6480464 PLA2G2A protein results in increased abundance of Thromboxane B2 CTD PMID:10027849 PLA2G2A Human trichloroethene decreases expression ISO Pla2g2a (Rattus norvegicus) 6480464 Trichloroethylene results in decreased expression of PLA2G2A mRNA CTD PMID:33387578 PLA2G2A Human trichostatin A increases expression EXP 6480464 trichostatin A results in increased expression of PLA2G2A mRNA CTD PMID:24935251 and PMID:26272509 PLA2G2A Human trichostatin A multiple interactions EXP 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 PLA2G2A Human triclosan increases expression EXP 6480464 Triclosan results in increased expression of PLA2G2A mRNA CTD PMID:30510588 PLA2G2A Human ursodeoxycholic acid multiple interactions ISO Pla2g2a (Rattus norvegicus) 6480464 Ursodeoxycholic Acid inhibits the reaction [Azoxymethane results in increased activity of PLA2G2A protein] more ... CTD PMID:10025872 PLA2G2A Human valproic acid affects expression EXP 6480464 Valproic Acid affects the expression of PLA2G2A mRNA CTD PMID:25979313 PLA2G2A Human valproic acid multiple interactions EXP 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 PLA2G2A Human valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of PLA2G2A mRNA CTD PMID:23179753 more ... PLA2G2A Human vanadium atom increases expression EXP 6480464 Vanadium results in increased expression of PLA2G2A mRNA CTD PMID:19000753 PLA2G2A Human vanadium(0) increases expression EXP 6480464 Vanadium results in increased expression of PLA2G2A mRNA CTD PMID:19000753 PLA2G2A Human varespladib decreases activity EXP 6480464 varespladib results in decreased activity of PLA2G2A protein CTD PMID:10027849 PLA2G2A Human varespladib decreases activity ISO Pla2g2a (Rattus norvegicus) 6480464 varespladib results in decreased activity of PLA2G2A protein CTD PMID:10027849 PLA2G2A Human varespladib multiple interactions EXP 6480464 varespladib inhibits the reaction [PLA2G2A protein results in increased abundance of Thromboxane A2 metabolite] and varespladib inhibits the reaction [PLA2G2A protein results in increased abundance of Thromboxane B2] CTD PMID:10027849 PLA2G2A Human varespladib methyl multiple interactions EXP 6480464 varespladib methyl inhibits the reaction [IL1B protein results in increased secretion of PLA2G2A protein] CTD PMID:19765281 PLA2G2A Human vinclozolin affects expression ISO Pla2g2a (Rattus norvegicus) 6480464 vinclozolin affects the expression of PLA2G2A mRNA CTD PMID:19015723 PLA2G2A Human vorinostat multiple interactions EXP 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PLA2G2A mRNA CTD PMID:27188386 PLA2G2A Human vorinostat increases expression EXP 6480464 vorinostat results in increased expression of PLA2G2A mRNA CTD PMID:26272509
